What is the expected growth forecast for the Gelatin Haemostatic Matrix market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Gelatin Haemostatic Matrix market?

Increasing surgical procedures and growing demand for haemostatic agents drive the market.

What are the major challenges facing the Gelatin Haemostatic Matrix market?

Stringent regulatory requirements and high production costs are major challenges.

Which regions are the leaders in the Gelatin Haemostatic Matrix market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Gelatin Haemostatic Matrix market?

Top companies include Johnson & Johnson, Baxter, and Pfizer, among others.

What are the future opportunities in the Gelatin Haemostatic Matrix market?

Emerging economies and increasing demand for minimally invasive surgeries offer future opportunities.

How does technology impact the Gelatin Haemostatic Matrix market?

Advances in biomaterials and manufacturing technologies improve product efficacy and safety.

What is the regulatory landscape for the Gelatin Haemostatic Matrix market?

Regulatory bodies like FDA and CE ensure compliance with strict standards and guidelines.

What is the future outlook for the Gelatin Haemostatic Matrix market size?

The market is expected to reach USD 2.5 billion by 2033, driven by growing demand.

Gelatin Haemostatic Matrix Growth Drivers & Forecast Analysis 2033

Gelatin Haemostatic Matrix by Application (Orthopedics, Obstetrics and Gynecology, General Surgery, Otolaryngology, Other), by Types (4 ml, 5 ml, 6 ml, 8 ml, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 71

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 71

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gelatin Haemostatic Matrix Market Overview

The Gelatin Haemostatic Matrix market refers to the industry involving the production and distribution of gelatin-based haemostatic matrices used to control bleeding in surgical procedures. As a critical component in the medical sector, the Gelatin Haemostatic Matrix market size is expected to witness significant growth, driven by its increasing demand in various surgical applications. The growth outlook for this market is promising, with a projected market forecast indicating a steady expansion over the forecast period. The industry expansion is primarily attributed to advancements in medical technology, growing demand for effective haemostatic agents, and an increasing number of surgical procedures globally. According to recent estimates, the current Gelatin Haemostatic Matrix market size is approximately $230 million.

Loading chart…

The Gelatin Haemostatic Matrix market is expected to grow at a CAGR of 8% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic diseases, a growing geriatric population, and rising healthcare expenditure. Key forces shaping the industry include technology shifts towards more effective and minimally invasive surgical procedures, regulations governing the use of haemostatic agents, and consumer behavior demanding better patient outcomes. The largest region for the Gelatin Haemostatic Matrix market is North America, while the fastest-growing region is expected to be the Asia-Pacific. The market growth is further driven by the increasing adoption of gelatin haemostatic matrices in various surgical applications, including cardiovascular, neurological, and orthopaedic surgeries.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; BORAYER
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gelatin Haemostatic Matrix market is poised for significant growth, driven by increasing demand for effective haemostatic agents in surgical procedures. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting consumer preferences.

Growth Drivers2 items

Advances in biotechnology and biomaterials have led to the development of more effective and biocompatible Gelatin Haemostatic Matrix products, driving market growth and expanding the Gelatin Haemostatic Matrix market size.

The rising number of surgical procedures, particularly in the cardiovascular and neurosurgical fields, has increased the demand for haemostatic agents, contributing to the growth forecast of the Gelatin Haemostatic Matrix market.

Restraints2 items

Stringent regulatory requirements and quality standards for Gelatin Haemostatic Matrix products can limit market growth by increasing the time and cost associated with product development and approval.

The availability of alternative haemostatic agents, such as collagen-based products, may restrain the growth of the Gelatin Haemostatic Matrix market by providing consumers with a range of options.

Opportunities2 items

The growing demand for minimally invasive surgical procedures presents an opportunity for the development of novel Gelatin Haemostatic Matrix products that can be used in these procedures, driving market growth and innovation.

Emerging markets, particularly in Asia-Pacific and Latin America, offer significant opportunities for expansion and growth of the Gelatin Haemostatic Matrix market, driven by increasing healthcare expenditure and improving infrastructure.

Challenges2 items

The Gelatin Haemostatic Matrix market faces challenges related to supply chain disruptions and raw material shortages, which can impact product availability and pricing.

The need for continuous innovation and investment in research and development to stay competitive in the market and address emerging trends and technologies, such as nanotechnology and tissue engineering, poses a significant challenge for market players.

Market Segmentation

Loading chart…

The Gelatin Haemostatic Matrix market can be segmented based on Application, which refers to the specific uses of Gelatin Haemostatic Matrix in various medical procedures. This segmentation category contributes significantly to the overall market size, as different applications have distinct demand patterns and growth prospects. The Gelatin Haemostatic Matrix segmentation by application includes cardiovascular surgery, neurosurgery, and orthopedic surgery, among others. Understanding these application-based segments is crucial for industry players to develop targeted strategies and capitalize on emerging opportunities.

Another critical segmentation category in the Gelatin Haemostatic Matrix market is Types, which encompasses various subtypes such as [object Object] and [object Object]. These subtypes differ in terms of their composition, properties, and suitability for specific applications. The Types segmentation contributes to the market size by catering to diverse customer needs and preferences. By analyzing the market taxonomy, including the Gelatin Haemostatic Matrix segmentation, researchers and industry stakeholders can gain valuable insights into the competitive landscape and identify areas for innovation and growth.

Gelatin Haemostatic Matrix Segmentation Breakdown12 items

Application

Orthopedics

Obstetrics and Gynecology

General Surgery

Otolaryngology

Other

Types

4 ml

5 ml

6 ml

8 ml

Other

Regional Insights

Loading chart…

The Gelatin Haemostatic Matrix market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics of the aging population, and established infrastructure. In Europe, drivers include policies supporting medical innovation, a strong ecosystem, and significant investments in research and development. Asia Pacific is driven by adoption of new technologies, large demographics, and increasing investments in healthcare. Latin America and Middle East & Africa are driven by growing adoption, improving infrastructure, and increasing investments in healthcare.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by its large and growing population, increasing adoption of advanced medical technologies, and significant investments in healthcare infrastructure. The Gelatin Haemostatic Matrix market is expected to experience significant growth in the coming years, driven by increasing demand for effective haemostatic solutions and growing adoption of advanced medical technologies.

Competitive Landscape

The Gelatin Haemostatic Matrix market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. Key competitive levers include regulatory approvals, certifications, and strategic partnerships. Understanding the Gelatin Haemostatic Matrix competitive landscape is crucial for companies to navigate this complex environment, where global players often have an advantage in terms of economies of scale and reach, but local companies can differentiate themselves through localized offerings and stronger relationships with regional healthcare systems.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. They focus on technological advancements, service model innovation, and channel strength to stay competitive. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies must carefully consider their strategic focus, whether it be regional expansion, vertical integration, or innovation pipeline development. The following companies illustrate different strategic approaches:

Johnson & Johnson: regional expansion

Baxter: premium pricing

BORAYER: local manufacturing

Baxter: innovation pipeline

Johnson & Johnson: OEM tie-ups

BORAYER: vertical integration

Key Gelatin Haemostatic Matrix Companies3 items

Johnson & Johnson

Baxter

BORAYER

Market Ecosystem

The Gelatin Haemostatic Matrix ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with value created and captured at each stage. Upstream participants provide the necessary raw materials and components, which are then integrated by midstream players, and ultimately, the finished products are delivered to downstream end users through various channels.

Raw material suppliers — provide gelatin and other components

Technology providers — develop haemostatic technologies

OEMs / manufacturers — produce Gelatin Haemostatic Matrix products

Distributors / channel partners — supply products to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and use Gelatin Haemostatic Matrix products

Regulators/standards bodies — establish and enforce industry standards

In the Gelatin Haemostatic Matrix ecosystem, value flows through the various participants, with each stage influencing the next. Control points, such as regulatory approvals and industry standards, can significantly impact the adoption of Gelatin Haemostatic Matrix products. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can influence the decisions of end users and other participants. A thorough value chain analysis is necessary to understand the intricacies of the Gelatin Haemostatic Matrix ecosystem and identify potential bottlenecks and opportunities for growth.

Recent Industry Insights

The Gelatin Haemostatic Matrix industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships between key players have focused on enhancing product portfolios and expanding distribution networks. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the industry.

Furthermore, several companies have launched innovative products and technologies, aiming to improve the efficacy and safety of gelatin haemostatic matrices. Regulatory changes have also influenced the industry, with updated guidelines and standards being implemented to ensure better quality and performance of these matrices. These developments are expected to drive growth in the Gelatin Haemostatic Matrix market, with funding rounds and expansions supporting the industry's evolution.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Gelatin Haemostatic Matrix market. The Gelatin Haemostatic Matrix market outlook is promising, driven by increasing demand for effective haemostatic agents in surgical procedures. The market attractiveness is moderate, with a competitive intensity that is expected to rise due to the entry of new players. In the long term, the market is expected to grow steadily, driven by advancements in the innovation landscape and rising awareness about the benefits of gelatin haemostatic matrices.

The demand-supply balance is currently skewed, with supply outpacing demand. However, this is expected to change as the market grows. Key risk factors include regulatory challenges and intense competition. Overall, the Gelatin Haemostatic Matrix market presents opportunities for growth, but players must navigate the competitive landscape and innovate to stay ahead.

11 items

1. Executive Summary

2. Gelatin Haemostatic Matrix Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gelatin Haemostatic Matrix Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Gelatin Haemostatic Matrix Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Orthopedics

6.1.2. Obstetrics and Gynecology

6.1.3. General Surgery

6.1.4. Otolaryngology

6.1.5. Other

6.2. Global Gelatin Haemostatic Matrix Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 4 ml

6.2.2. 5 ml

6.2.3. 6 ml

6.2.4. 8 ml

6.2.5. Other

6.3. Global Gelatin Haemostatic Matrix Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Gelatin Haemostatic Matrix Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gelatin Haemostatic Matrix Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gelatin Haemostatic Matrix Market Competition by Key Manufacturers

8.1. Global Gelatin Haemostatic Matrix Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Gelatin Haemostatic Matrix: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Baxter

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BORAYER

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gelatin Haemostatic Matrix Market

Figure 4: Global Gelatin Haemostatic Matrix Market: Drivers

Figure 5: Global Gelatin Haemostatic Matrix Market: Challenges

Figure 6: Global Gelatin Haemostatic Matrix Market: Trends

Figure 7: Global Gelatin Haemostatic Matrix Market: Opportunity

Figure 8: Global Gelatin Haemostatic Matrix Market: Restraint

Figure 9: Global Gelatin Haemostatic Matrix Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Gelatin Haemostatic Matrix Market Value (USD Million) By Region

Figure 15: Global Gelatin Haemostatic Matrix Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Gelatin Haemostatic Matrix Market Value (USD Million) By Region

Figure 23: Global Gelatin Haemostatic Matrix Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global Gelatin Haemostatic Matrix Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gelatin Haemostatic Matrix Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gelatin Haemostatic Matrix Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Gelatin Haemostatic Matrix Market Value (USD Million) By Region

Table 10: Global Gelatin Haemostatic Matrix Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Gelatin Haemostatic Matrix Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Gelatin Haemostatic Matrix Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Gelatin Haemostatic Matrix Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: Baxter Basic Information And Sales Area

Table 33: Baxter. Products Portfolio

Table 34: BORAYER Basic Information And Sales Area

Table 35: BORAYER. Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global Gelatin Haemostatic Matrix Market Value (USD Million) By Region

Table 41: Global Gelatin Haemostatic Matrix Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Application

Table 44: North America Market Value (USD Million) (2025-2032) By Types

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Application

Table 47: Europe Market Value (USD Million) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Application

Table 53: South America Market Value (USD Million) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Gelatin Haemostatic Matrix Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; Baxter; BORAYER
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The availability of alternative haemostatic agents, such as collagen-based products, may restrain the growth of the Gelatin Haemostatic Matrix market by providing consumers with a range of options.

Opportunities2 items

Challenges2 items

The Gelatin Haemostatic Matrix market faces challenges related to supply chain disruptions and raw material shortages, which can impact product availability and pricing.

Market Segmentation

Loading chart…

Gelatin Haemostatic Matrix Segmentation Breakdown12 items

Application

Orthopedics

Obstetrics and Gynecology

General Surgery

Otolaryngology

Other

Types

4 ml

5 ml

6 ml

8 ml

Other

Regional Insights

Loading chart…

Competitive Landscape

Johnson & Johnson: regional expansion

Baxter: premium pricing

BORAYER: local manufacturing

Baxter: innovation pipeline

Johnson & Johnson: OEM tie-ups

BORAYER: vertical integration

Key Gelatin Haemostatic Matrix Companies3 items

Johnson & Johnson

Baxter

BORAYER

Market Ecosystem

Raw material suppliers — provide gelatin and other components

Technology providers — develop haemostatic technologies

OEMs / manufacturers — produce Gelatin Haemostatic Matrix products

Distributors / channel partners — supply products to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and use Gelatin Haemostatic Matrix products

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents